Cost of disorders of the brain in Europe 2010

Gustavsson, Anders, Svensson, Mikael, Jacobi, Frank, Allgulander, Christer, Alonso, Jordi, Beghi, Ettore, Dodel, Richard, Ekman, Mattias +35 more·2011·European Neuropsychopharmacology

Cited by (1,008)

Items 801–900 of 1,008

  1. Older age, higher perceived disability and depressive symptoms predict the amount and severity of work-related difficulties in persons with multiple sclerosis
    Alberto Raggi, Ambra Mara Giovannetti, Silvia Schiavolin, Laura Brambilla, Greta Brenna, Paolo Agostino Confalonieri, Francesca Cortese, Rita Frangiamore, Matilde Leonardi, Renato Mantegazza et al. · 2018 · Disability and Rehabilitation
  2. Time Trends of the Incidence, Prevalence, and Mortality of Parkinsonism
    Jessica J. Wong, Jeffrey C. Kwong, Karen Tu, Debra A. Butt, Ray Copes, Andrew S. Wilton, Brian James Murray, Alexander Kopp, Hong Chen · 2019 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  3. Linking Individual Patient Data to Estimate Incidence and Prevalence of Parkinson's Disease by Comparing Reports of Neurological Services and Pharmacy Prescription Refills at a Nationwide Level
    Szabolcs Szatmári, András Ajtay, Mónika Bálint, Annamária Takáts, Ferenc Oberfrank, Dániel Bereczki · 2019 · Frontiers in Neurology
  4. Acupuncture in Adult and Pediatric Headache: A Narrative Review
    Elizabeth Doll, Brooke M. Threlkeld, Danielle M. Graff, Rob Clemons, Olivia Mittel, Michael Sowell, Mark McDonald · 2019 · Neuropediatrics
  5. Dementia care in public health in Brazil and the world: A systematic review
    Bianca Bolzan Cieto, Gabriela Gallego Valera, Glaucia Bueno Soares, Roberta Hehl de Sylos Cintra, Francisco Assis Carvalho Vale · 2014 · Dementia & Neuropsychologia
  6. Brain–Machine Interfaces in Stroke Neurorehabilitation
    Surjo Raphael Soekadar, Stefano Silvoni, Leonardo G. Cohen, Niels Birbaumer · 2014 · Springer eBooks
  7. Assessing the costs and cost-effectiveness of ICare internet-based interventions (protocol)
    Beecham, Jennifer, Bonin, Eva-Maria, Görlich, Dennis, Baños, Rosa, Beintner, Ina, Buntrock, Claudia, Bolinski, Felix, Botella, Cristina, Ebert, David Daniel, Herrero, Rocio et al. · 2019 · Internet Interventions
  8. Repetitive negative thinking: transdiagnostic correlate and risk factor for mental disorders? A proof-of-concept study in German soldiers before and after deployment to Afghanistan
    Hummel, Katrin V., Trautmann, Sebastian, Venz, John, Thomas, Sarah, Schäfer, Judith · 2021 · BMC Psychology
  9. Epidemiology and Economic Burden of Sleep Disorders in Europe
    Claudio L. Bassetti, Luisa Sophie Welter, Mateo Montes Martínez, Nikolai Mühlberger, Paul Boon, Thomas Berger, Günther Deuschl, Marjan Arvandi, Maria Konti, María Lolich et al. · 2026 · European Journal of Neurology
  10. Health care utilization and cost-effectiveness analyses in prevention studies in the mental health care field
    Elke Voß, Hans Joachim Salize · 2016 · Mental Health & Prevention
  11. Self-Compassion and Anxiety in Adolescents with and without Anxiety Disorder
    Edibe Tali, Eva S. Potharst, Esther I. de Bruin, Elisabeth M. W. J. Utens · 2023 · Children
  12. The health and economic burden of brain disorders: Consequences for investment in diagnosis, treatment, prevention and R&D
    Yunfei Li, Linus Jönsson · 2025 · Cerebral Circulation - Cognition and Behavior
  13. Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis
    Dang Wei, Anna Freydenzon, Octave Guinebretiere, Karim Zaidi, Fen Yang, Weimin Ye, Niklas Hammar, Naomi R. Wray, Naomi R. Wray, Maria Feychting et al. · 2025 · EBioMedicine
  14. In search of innovative therapeutics for neuropsychiatric disorders: The case of neurodegenerative diseases
    Jean Féger, Étienne C. Hirsch · 2014 · Annales Pharmaceutiques Françaises
  15. Key factors that influence government policies and decision making about healthcare priorities: Lessons for the field of eating disorders
    Harvey Whiteford, Ruth Striegel Weissman · 2017 · International Journal of Eating Disorders
  16. Excess costs from functional somatic syndromes in Germany — An analysis using entropy balancing
    Helen Grupp, Claudia Kaufmann, Hans‐Helmut König, Florian Bleibler, Beate Wild, Joachim Szécsényi, Wolfgang Herzog, Dieter Schellberg, Rainer Schaefert, Alexander Konnopka · 2017 · Journal of Psychosomatic Research
  17. Lifetime and 12-month prevalence estimates for mental disorders in northeastern Germany: findings from the Study of Health in Pomerania
    Eva Asselmann, Katja Beesdo‐Baum, Alfons O. Hamm, Carsten Oliver Schmidt, Johannes Hertel, Hans Jörgen Grabe, Christiane A. Pané‐Farré · 2018 · European Archives of Psychiatry and Clinical Neuroscience
  18. Collaborative mental health care program versus a general practitioner program and usual care for treatment of patients with mental or neurological disorders in Germany: protocol of a multiperspective evaluation study
    Julia Luise Magaard, Sarah Liebherz, Hanne Melchior, Alexander Engels, Hans‐Helmut König, Levente Kriston, Holger Schulz, J. Jahed, Anna Levke Brütt, Katrin Christiane Reber et al. · 2018 · BMC Psychiatry
  19. Depression, neuroticism and 2D:4D ratio: evidence from a large, representative sample
    Leopold Maria Lautenbacher, Levent Neyse · 2020 · Scientific Reports
  20. A Two-Day Acceptance and Commitment Therapy (ACT) Workshop Increases Presence and Work Functioning in Healthcare Workers
    Rainer Gaupp, Marc Walter, Klaus Bader, Charles Benoy, Undine Emmi Lang · 2020 · Frontiers in Psychiatry
  21. Naltrexone is neuroprotective against traumatic brain injury in mu opioid receptor knockout mice
    Yu-Syuan Wang, Tsai‐Wei Hung, Eun‐Kyung Bae, Kuo‐Jen Wu, Wei Hsieh, Seong‐Jin Yu · 2021 · CNS Neuroscience & Therapeutics
  22. Indirect costs attributed to headache: A nation-wide survey of an active working population
    Raquel Gil‐Gouveia, Raquel Miranda · 2021 · Cephalalgia
  23. Association of plasma tryptophan concentration with periaqueductal gray matter functional connectivity in migraine patients
    Kinga Gecse, Dóra Dobos, Csaba Aranyi, Attila Galambos, Dániel Baksa, Natália Kocsel, Edina Szabó, Dorottya Pap, Dávid Virág, Krisztina Ludányi et al. · 2022 · Scientific Reports
  24. Usefulness of the International Personality Disorder Examination screening questionnaire for borderline and impulsive personality pathology in adolescents
    Ernesto M. Magallón-Neri, María Forns, Gloria Canalda, J. Eugenio De La Fuente, Raquel Álvarez García, Esther González, Anaís Lara, Josefina Castro‐Fornieles · 2012 · Comprehensive Psychiatry
  25. Parity of esteem begins at home: translating empirical psychiatric research into effective public mental health
    James Bowes Kirkbride, Peter Brian Jones · 2013 · Psychological Medicine
  26. Public spending for illegal drug and alcohol treatment in hospitals: an EU cross-country comparison
    Delfine Lievens, Freya Vander Laenen, Johan R. Christiaens · 2014 · Substance Abuse Treatment Prevention and Policy
  27. Integrated Care Pathways for Schizophrenia: A Scoping Review
    Sheng Chen, Saima Awan, Tarek K. Rajji, Petal S. Abdool, Tony Peter George, April A. Collins, Sean A. Kidd · 2015 · Administration and Policy in Mental Health and Mental Health Services Research
  28. Targeting the GABAB Receptor for the Treatment of Depression and Anxiety Disorders
    Daniela Felice, Olivia F. O’Leary, John F. Cryan · 2016 · Springer eBooks
  29. The multiple sclerosis work difficulties questionnaire: translation and cross-cultural adaptation to Turkish and assessment of validity and reliability
    Turhan Kahraman, Asiye Tuba Özdoğar, Cynthia A. Honan, Özge Ertekin, Serkan Özakbaş · 2018 · Disability and Rehabilitation
  30. Epidemiologie psychischer Störungen
    Frank Jacobi, Sonia Kessler-Scheil · 2013 · Psychotherapeut
  31. Associations between Physical Activity Level and Mental Health in the Spanish Population: A Cross-Sectional Study
    Ángel Manuel Denche-Zamorano, My works are correct, but my institutional affiliations are incorrect. Some records link me to Instituto de Arqueología-Mérida, which is not my institution. My correct affiliation is University of Extremadura, Rafael Gómez-Galán, Juan Manuel Franco-García, Jorge Carlos‐Vivas, María Mendoza-Muñoz, Jorge Rojo-Ramos, Alejandro Vega-Muñoz, Nicolás Contreras-Barraza, Konstantinos Gianikellis et al. · 2022 · Healthcare
  32. Sharing knowledge to advance healthcare policies in Europe for people living with dementia and their carers: the ALCOVE project
    the ALCOVE GROUP, Christine Barr, N. Riolacci‐Dhoyen, Maggie Galbraith, Armelle Leperre‐Desplanques · 2012 · Archives of Public Health
  33. Mental Health and Work
    Iris Arends, Niklas Baer, Veerle Miranda, Christopher Prinz, Shruti Singh · 2014 · OECD social employment and migration working papers
  34. Biomarker Development for Brain-Based Disorders: Recent Progress in Psychiatry.
    James O Ebot Enaw, Alicia K. Smith · 2013 · Journal of Neurology and Psychology
  35. Burden of Disease of Borderline Personality Disorder: A Comprehensive Evaluation of Quality of Life and Societal Cost of Illness
    Carlijn J. M. Wibbelink, Arnoud Roger Arntz, Jan Henk Kamphuis, Iuno Z. Groot, Roland Sinnaeve, Silvia Evers · 2025 · Journal of Clinical Psychology
  36. Personalized mental health: Artificial intelligence technologies for treatment response prediction in anxiety disorders
    Ulrike Lueken, Tim Hahn · 2019 · Elsevier eBooks
  37. Association between obstructive sleep apnea and multiple involuntary job loss history among recently unemployed adults
    Graciela E. Silva, Stuart F. Quan, Taryn E McMorrow, Rueben Bautista, Melanie L. Bell, Patricia L. Haynes · 2020 · Sleep Health
  38. Social burden of three major diseases in Japan: A time trend and future projections using the comprehensive cost of illness method
    Koki Hirata, Kunichika Matsumoto, Yosuke Hatakeyama, Ryo Onishi, Kanako Seto, Tomonori Hasegawa · 2023 · PLoS ONE
  39. The cost of mental health: Where do we stand in France?
    Charles Laidi, Laeticia Blampain Segar, Ophélia Godin, Anne de Danne, Marion Leboyer, Isabelle Durand‐Zaleski · 2023 · European Neuropsychopharmacology
  40. Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial
    Elias M. Wagner, Wolfgang Strube, Thomas Görlitz, Aslihan Aksar, Ingrid Oliveira Bosenbecker Bauer, Mattia Campana, Joanna Moussiopoulou, Alexander Hapfelmeier, Petra Wagner, Silvia Egert-Schwender et al. · 2023 · Pharmacopsychiatry
  41. Care of Late‐Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries
    Christopher Kruse, Anna Luísa Lipinski, Malte Verheyen, Monika Balzer‐Geldsetzer, Michael Wittenberg, Stefan Lorenzl, Carmen Richinger, Christian Schmotz, Lars Tönges, Dirk Woitalla et al. · 2024 · Movement Disorders
  42. The impact of bladder problems on well-being in multiple sclerosis – A cross-sectional study
    Sabrina Islamoska, Christian Riis Forman, Jalesh N. Panicker, Peter Flachenecker, V. Phé, Giampaolo Brichetto, Bertil F. M. Blok, Kim Bundvig Barken · 2024 · Multiple Sclerosis and Related Disorders
  43. Delivering stepped care for depression in general practice: Results of a survey amongst general practitioners in the Netherlands
    Henny Sinnema, Gerdien C. Franx, Jan Spijker, Marijke Ruiter, Harry van Haastrecht, Peter F.M. Verhaak, Jasper Nuyen · 2013 · European Journal of General Practice
  44. Positive blood alcohol level in severe traumatic brain injury is associated with better long-term functional outcome
    Shahin Mohseni, Bo‐Michael Bellander, Louis Riddez, Peep Talving, Eric Peter Thelin · 2016 · Brain Injury
  45. Morphological and Functional Evaluation of Axons and their Synapses during Axon Death in Drosophila melanogaster
    Maria Paglione, Arnau Llobet Rosell, Jean‐Yves Chatton, Lukas Jakob Neukomm · 2020 · Journal of Visualized Experiments
  46. Prediction Along a Developmental Perspective in Psychiatry: How Far Might We Go?
    Frauke Nees, Lorenz Deserno, Nathalie E. Holz, Marcel Romanos, Tobias Banaschewski · 2021 · Frontiers in Systems Neuroscience
  47. Simultaneous Inhibitory Effects of All-Trans Astaxanthin on Acetylcholinesterase and Oxidative Stress
    Xin Wang, Tao Zhang, Xiaochen Chen, Yating Xu, Zhipeng Li, Yuanfan Yang, Xiping Du, Zedong Jiang, Hui Ni · 2022 · Marine Drugs
  48. Factors related to sustainable employment of people with acquired brain injury or spinal cord injury: The employer's perspective
    Barbara Schiffmann, Monika Elisabeth Finger, Katarzyna Karcz, Stefan Staubli, Bruno Trezzini · 2022 · Frontiers in Rehabilitation Sciences
  49. Wie teuer wird es wirklich?
    Eva‐Maria Wunsch, Sören Kliem, Anja Grocholewski, Christoph Bernhard Kröger · 2013 · Psychologische Rundschau
  50. Genetics and genomic medicine in Mali: challenges and future perspectives
    Guida Landouré, Oumar Samassékou, Mahamadou Traoré, Katherine G. Meilleur, Cheick Oumar Guinto, Barrington G. Burnett, Charlotte J. Sumner, Kenneth H. Fischbeck · 2016 · Molecular Genetics & Genomic Medicine
  51. Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL)
    Judit Simon, John Richard Geddes, Alexandra Gardiner, Jennifer Rendell, Guy M. Goodwin, Susanne Mayer · 2018 · Bipolar Disorders
  52. Hospitalization rates and resource utilization of schizophrenic patients switched from oral antipsychotics to aripiprazole-depot in Germany
    Christoph Potempa, Reinhard P. T. Rychlik · 2018 · Health Economics Review
  53. Dynamics of device-based treatments for Parkinson’s disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa–carbidopa intestinal gel, and deep brain stimulation
    Daniel Richter, Dirk Bartig, Wolfgang H. Jost, Christoph Jörges, Britta Stumpe, Ralf Gold, Christos Krogias, Lars Tönges · 2019 · Journal of Neural Transmission
  54. The Effect of Therapeutic Horticulture on Depression and Kynurenine Pathways
    Timea Hitter Buru, Éva KÁLLAY, Loredana Elena Olar, Răzvan Ștefan, Erzsébet Buta, Silvia CHIOREAN, Maria Cantor, Ionel Papuc · 2019 · Notulae Botanicae Horti Agrobotanici Cluj-Napoca
  55. Short-term functional outcome in psychotic patients: results of the Turku early psychosis study (TEPS)
    Raimo K. R. Salokangas, Tiina From, Tuula Ilonen, Sinikka H. Luutonen, Markus Heinimaa, Reetta-Liina Armio, Heikki Laurikainen, Maija Walta, Janina Paju, Anna Toivonen et al. · 2021 · BMC Psychiatry
  56. Circular economy of waste in agrifood supply chain: A review
    Omar Ouro‐Salim, Patrícia Guarnieri · 2022 · Thunderbird International Business Review
  57. Pattern and predictors of sick leave among users of antidepressants: A Danish retrospective register-based cohort study
    Christiane Gasse, Liselotte Vogdrup Petersen, Julien Chollet, Delphine Saragoussi · 2013 · Journal of Affective Disorders
  58. MicroRNA’s impact on neurotransmitter and neuropeptide systems: small but mighty mediators of anxiety
    Martinetz, Stefanie · 2016 · Pflügers Archiv - European Journal of Physiology
  59. Effects of Induced Mindfulness at Night on Repetitive Negative Thinking: Ecological Momentary Assessment Study
    Amanda Sommerhoff, Thomas W. Ehring, Keisuke Takano · 2023 · JMIR Mental Health
  60. Sentiment Classification of Anxiety-Related Texts in Social Media via Fuzing Linguistic and Semantic Features
    Jianghong Zhu, Zhenwen Zhang, Zhihua Guo, Zepeng Li · 2024 · IEEE Transactions on Computational Social Systems
  61. Cueing Interventions for Gait and Balance in Parkinson’s Disease: A Scoping Review of Current Evidence
    Federica Giorgi, Danilo Donati, Roberto Tedeschi · 2024 · Applied Sciences
  62. A combined marker of early non-improvement and the occurrence of melancholic features improve the treatment prediction in patients with Major Depressive Disorders
    Stefanie Wagner, André Tadić, Sibylle Christine Roll, Alice Engel, Nadine Dreimüller, Jan Engelmann, Klaus Lieb · 2017 · Journal of Affective Disorders
  63. Machine Learning in Healthcare, Introduction and Real World Application Considerations
    Stavros Pitoglou · 2018 · International Journal of Reliable and Quality E-Healthcare
  64. Adverse drug event‐related hospitalisation in persons with neurodevelopmental disorders: a state‐wide retrospective cohort study
    Mingming Zhou, Wei Du, Luis Salvador‐Carulla, Nicholas Glasgow · 2019 · Journal of Intellectual Disability Research
  65. Der Gebrauch illegaler Substanzen im deutschsprachigen Raum
    Boris B. Quednow · 2019 · Forensische Psychiatrie Psychologie Kriminologie
  66. Behavioral, Physiological and EEG Activities Associated with Conditioned Fear as Sensors for Fear and Anxiety
    Jui‐Hong Chien, Luana Colloca, Anna Korzeniewska, Timothy J. Meeker, O. Joe Bienvenu, Mark Saffer, Fred A. Lenz · 2020 · Sensors
  67. Prevention of eating disorders—Efficacy and cost‐benefit of a school‐based program (“ MaiStep ”) in a randomized controlled trial (RCT)
    Vanessa Wolter, Florian Hammerle, Arne Buerger, Verena Ernst · 2021 · International Journal of Eating Disorders
  68. Individual placement and support and employment in personality disorders: a registry based cohort study
    Trees T. Juurlink, Femke Lamers, Hein J. F. van Marle, Wim Zwinkels, M. A. Spijkerman, Aartjan T.F. Beekman, Johannes R. Anema · 2022 · BMC Psychiatry
  69. Effects of Progesterone on Preclinical Animal Models of Traumatic Brain Injury: Systematic Review and Meta-analysis
    Raif Gregorio Nasre‐Nasser, Maria Manoela Rezende Severo, Gabriel Natan Pires, Mariana Appel Hort, Bruno Dutra Arbo · 2022 · Molecular Neurobiology
  70. A Newly Identified Monoterpenoid-Based Small Molecule Able to Support the Survival of Primary Cultured Dopamine Neurons and Alleviate MPTP-Induced Toxicity In Vivo
    Anastasiia Kotliarova, A. Podturkina, A. Pavlova, Daria S. Gorina, A. Lastovka, O. Ardashov, A. Rogachev, A. Izyurov, A. Arefieva, Alexander V. Kulikov et al. · 2022 · Molecules
  71. Effects of graphene oxide nanoparticles administration against reserpine-induced neurobehavioral damage and oxidative stress in an animal model of Parkinson's disease
    Mjid Oukhrib, Lahcen Tamegart, Abdeslam Assafi, Lamia Hejji, Abdelmonaim Azzouz, Luis Pérez‐Villarejo, Mohammed Haida, Mohamed Chraa, Halima Gamrani · 2023 · Food and Chemical Toxicology
  72. Cost Effectiveness of Lacosamide in the Adjunctive Treatment of Patients with Refractory Focal Epilepsy in Belgium
    Steven Simoens, Liesbet De Naeyer, Peter Dedeken · 2012 · CNS Drugs
  73. Development of a Prolonged-Release Pramipexole Transdermal Patch: In Vitro and In Vivo Evaluation
    Tingting Pu, Xiaohui Li, Yuming Sun, Xue Ding, Yaqing Pan, Qing Wang · 2016 · AAPS PharmSciTech
  74. Das deutsche Forschungsnetz zu psychischen Erkrankungen
    Michael Bauer, Tobias Banaschewski, Andreas Heinz, Inge Kamp‐Becker, Andreas Meyer‐Lindenberg, Frank Padberg, Michael A. Rapp, Rainer Rupprecht, Frank W. Schneider, Thomas G. Schulze et al. · 2016 · Der Nervenarzt
  75. El abordaje de la depresión en el ámbito del trabajo: recomendaciones clave
    Enrique Castellón Leal, Pere Ibern Regás, Margalida Gili, Guillermo Lahera, Javier Sanz González, Jerónimo Sáiz Ruiz · 2016 · Psiquiatría Biológica
  76. Shared Housing Arrangements in Germany—An Equitable Alternative to Long Term Care Services beyond Homes and Institutions?
    Lorraine Frisina Doetter, Achim Schmid · 2018 · International Journal of Environmental Research and Public Health
  77. Demand for neurological services in Central Eastern Europe: a 10‐year national survey in Hungary
    Ferenc Oberfrank, András Ajtay, Dániel Bereczki · 2018 · European Journal of Neurology
  78. The Mental Health in Austrian Teenagers (MHAT) Study: design, methodology, description of study population
    Michael D. Zeiler, Gudrun Wagner, Julia Philipp, Martina Nitsch, Stefanie Truttmann, Wolfgang Dür, Andreas F. K. Karwautz, Karin Waldherr · 2018 · Neuropsychiatrie
  79. Value of schizophrenia treatment II: Decision modelling for developing early detection and early intervention services in the Czech Republic
    Petr Winkler, Hana Marie Broulíková, Lucie Kondrátová, Martin Richard John Knapp, Paul Arteel, Patrice Boyer, Silvana Galderisi, Hilkka Kärkkäinen, Aagje Ieven, Pavel Mohr et al. · 2018 · European Psychiatry
  80. Prediction of prolonged treatment course for depressive and anxiety disorders in an outpatient setting: The Leiden routine outcome monitoring study
    Suzanne Boer, Olaf M. Dekkers, Saskia le Cessie, Ingrid V. E. Carlier, Albert M. van Hemert · 2018 · Journal of Affective Disorders
  81. THE PREVALENCE AND BURDEN OF MENTAL AND SUBSTANCE USE DISORDERS IN ROMANIA: FINDINGS FROM THE GLOBAL BURDEN OF DISEASE STUDY 2016
    Mihai-Bogdan Iovu, Alina Maria Breaz · 2019 · Psychiatria Danubina
  82. Fighting healthcare rocketing costs with value-based medicine: the case of stroke management
    Federico Esposti, Giuseppe Banfi · 2020 · BMC Health Services Research
  83. The cognitive anxiety sensitivity treatment (CAST) in anxiety prevention – Focus on separation anxiety and interoception
    Miriam A. Schiele, Melanie Vietz, Agnieszka Gajewska, Stefan Unterecker, Michael G. Gottschalk, Jürgen Deckert, Susanne Neufang, Norman Brad Schmidt, Katharina Domschke · 2021 · European Neuropsychopharmacology
  84. Does conurbation affect the risk of poor mental health? A population based record linkage study
    Aideen Maguire, Dermot O’Reilly · 2015 · Health & Place
  85. Emergency room access for recurring seizures: when and why
    Simona Balestrini, Claudia Cagnetti, Nicoletta Foschi, Laura Buratti, Cristina Petrelli, Simona Luzzi, Mauro Silvestrini, Leandro Provinciali · 2013 · European Journal of Neurology
  86. Effectiveness of Short‐Term Dynamic Group Psychotherapy in Primary Care for Patients with Depressive Symptoms
    Ignasi Bros Cugat, Pere Notó, Antonio Bulbena · 2016 · Clinical Psychology & Psychotherapy
  87. Neuropsychological Outcome and its Predictors Across the First Year after Ischaemic Stroke
    Suzanne Lyn Barker-Collo, Rita Krishnamurthi, Valery L. Feigin, Amy Jones, Alice Theadom, P. Alan Barber, Nicola Jayne Starkey, Kathryn McPherson, Elaine Carolyn Rush, Derrick Bennett · 2016 · Brain Impairment
  88. Trend in the Incidence and Prevalence of Dementia in the Faroe Islands
    Maria Skaalum Petersen, Marjun Restorff, Tórmóður Stórá, Gunhild Waldemar, Sofus Joensen · 2019 · Journal of Alzheimer s Disease
  89. Interventions for the management of obesity in people with bipolar disorder
    Agnes Tully, Edel Murphy, Siobhán Smyth, Yvonne Conway, John Richard Geddes, Declan Devane, John P. Kelly, Fionnuala Jordan · 2018 · Cochrane Database of Systematic Reviews
  90. Effectiveness of low-dose amitriptyline and mirtazapine for insomnia disorder: study protocol of a randomised, double-blind, placebo-controlled trial in general practice (the DREAMING study)
    Mette H Bakker, Jacqueline Geertruida Hugtenburg, Annemieke van Straten, Henriëtte Eveline van der Horst, Pauline Slottje · 2021 · BMJ Open
  91. Taste receptor type 1 member 3 is required for the fertility of male mice
    Woo-Jeong Shon, Hobin Seong, Jae Won Song, Dong‐Mi Shin · 2024 · Heliyon
  92. Cognitive behavioural therapy added to standard care for first-episode and recent-onset psychosis
    Susanna Franziska Mayer, Ciarán Corcoran, Liam Kennedy, Stefan Leucht, Irene Bighelli · 2024 · Cochrane Database of Systematic Reviews
  93. Exploring Neural Correlates between Anxiety and Inhibitory Ability: Evidence from Task‐Based fNIRS
    Difan Wang, Bingyan Lin, Ying Huang, Zh Yeng Chong, Jiaxue Du, Qin Yuan, Yinmayue Tang, Qiming Xu, Wei Xu · 2024 · Depression and Anxiety
  94. Is It Possible to Combine Non-Invasive Brain Stimulation and Evidence-Based Psychosocial Interventions in Schizophrenia? A Critical Review
    Jacopo Lisoni, Gabriele Nibbio, Antonio Baglioni, Simona Dini, Bianca Manera, Alessandra Maccari, Luca Altieri, Irene Calzavara‐Pinton, Andrea Zucchetti, Giacomo Deste et al. · 2024 · Brain Sciences
  95. Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol
    Stefan Viktor Vormfelde, Sonja Ortler, Tjalf Ziemssen · 2016 · JMIR Research Protocols
  96. HEADWORK Questionnaire: Why Do We Need a New Tool to Assess Work‐Related Disability in Patients With Migraine?
    Domenico D’Amico, Licia Grazzi, Eleonora Grignani, Matilde Leonardi, Emanuela Sansone, Alberto Raggi, The HEADWORK Study Group · 2020 · Headache The Journal of Head and Face Pain
  97. The economic impact of prevention, monitoring and treatment strategies for iodine deficiency disorders in Germany
    Monika Schaffner, Ursula Rochau, Nikolai Mühlberger, Annette Conrads‐Frank, Vjollca Qerimi, Gaby Sroczynski, Eftychia G. Koukkou, Betina Heinsbæk Thuesen, Henry Völzke, Wilhelm Oberaigner et al. · 2020 · Endocrine Connections
  98. An Evaluation of Medication Prescribing Patterns for Acute Migraine in the Emergency Department: A Scoping Review
    Jun Hua Lim, Leila Karimi, Tissa Wijeratne · 2021 · Journal of Clinical Medicine
  99. Food Waste from the View of Circular Economy: A Systematic Review of International Literature
    Omar Ouro‐Salim, Patrícia Guarnieri, Fabrício Oliveira Leitão · 2021 · Revista de Gestão Social e Ambiental
  100. Neuromodulation Treatments of Pathological Anxiety in Anxiety Disorders, Stressor-Related Disorders, and Major Depressive Disorder: A Dimensional Systematic Review and Meta-Analysis
    Florian Gay, Allison Singier, Bruno Aouizerate, Francesco Salvo, Thomas Bienvenu · 2022 · Frontiers in Psychiatry